PT1275641E - Derivados de benzeno-sulfonamida, processo para a sua preparacao e as composicoes farmaceuticas que os contem - Google Patents
Derivados de benzeno-sulfonamida, processo para a sua preparacao e as composicoes farmaceuticas que os contemInfo
- Publication number
- PT1275641E PT1275641E PT02291747T PT02291747T PT1275641E PT 1275641 E PT1275641 E PT 1275641E PT 02291747 T PT02291747 T PT 02291747T PT 02291747 T PT02291747 T PT 02291747T PT 1275641 E PT1275641 E PT 1275641E
- Authority
- PT
- Portugal
- Prior art keywords
- benzeno
- contain
- preparation
- pharmaceutical compositions
- sulfonamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0109339A FR2827280B1 (fr) | 2001-07-13 | 2001-07-13 | Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1275641E true PT1275641E (pt) | 2005-05-31 |
Family
ID=8865462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02291747T PT1275641E (pt) | 2001-07-13 | 2002-07-11 | Derivados de benzeno-sulfonamida, processo para a sua preparacao e as composicoes farmaceuticas que os contem |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6541471B1 (pt) |
| EP (1) | EP1275641B1 (pt) |
| JP (1) | JP3770858B2 (pt) |
| KR (1) | KR100503157B1 (pt) |
| CN (1) | CN1186318C (pt) |
| AR (1) | AR035257A1 (pt) |
| AT (1) | ATE286877T1 (pt) |
| AU (1) | AU2002300092B2 (pt) |
| BR (1) | BR0202685A (pt) |
| CA (1) | CA2393995C (pt) |
| DE (1) | DE60202554T2 (pt) |
| DK (1) | DK1275641T3 (pt) |
| EA (1) | EA005376B1 (pt) |
| ES (1) | ES2234994T3 (pt) |
| FR (1) | FR2827280B1 (pt) |
| HK (1) | HK1050675A1 (pt) |
| HU (1) | HUP0202284A3 (pt) |
| MX (1) | MXPA02006853A (pt) |
| NO (1) | NO20023390L (pt) |
| NZ (1) | NZ520141A (pt) |
| PL (1) | PL355009A1 (pt) |
| PT (1) | PT1275641E (pt) |
| SI (1) | SI1275641T1 (pt) |
| ZA (1) | ZA200205597B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106083546A (zh) * | 2016-06-20 | 2016-11-09 | 上海引盛生物科技有限公司 | 一种3,5‑二溴苯甲醛的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02304022A (ja) * | 1989-05-18 | 1990-12-17 | Mitsubishi Kasei Corp | セロトニン拮抗剤 |
| US5364866A (en) * | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| EP0472053B1 (en) * | 1990-08-20 | 1998-06-17 | Eisai Co., Ltd. | Sulfonamide derivatives |
| TW219358B (pt) * | 1991-12-20 | 1994-01-21 | Hokuriku Pharmaceutical | |
| GB9220137D0 (en) * | 1992-09-23 | 1992-11-04 | Pfizer Ltd | Therapeutic agents |
| JPH0753505A (ja) * | 1992-10-01 | 1995-02-28 | Hokuriku Seiyaku Co Ltd | ベンゼンスルホンアミド誘導体及びその用途 |
| FR2760235B1 (fr) * | 1997-02-28 | 1999-04-09 | Adir | Nouveaux derives de benzenesulfonylamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-07-13 FR FR0109339A patent/FR2827280B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-11 MX MXPA02006853A patent/MXPA02006853A/es active IP Right Grant
- 2002-07-11 PL PL02355009A patent/PL355009A1/xx not_active Application Discontinuation
- 2002-07-11 ES ES02291747T patent/ES2234994T3/es not_active Expired - Lifetime
- 2002-07-11 DK DK02291747T patent/DK1275641T3/da active
- 2002-07-11 EP EP02291747A patent/EP1275641B1/fr not_active Expired - Lifetime
- 2002-07-11 SI SI200230073T patent/SI1275641T1/xx unknown
- 2002-07-11 AT AT02291747T patent/ATE286877T1/de not_active IP Right Cessation
- 2002-07-11 PT PT02291747T patent/PT1275641E/pt unknown
- 2002-07-11 DE DE60202554T patent/DE60202554T2/de not_active Expired - Fee Related
- 2002-07-12 BR BR0202685-6A patent/BR0202685A/pt not_active IP Right Cessation
- 2002-07-12 US US10/195,018 patent/US6541471B1/en not_active Expired - Fee Related
- 2002-07-12 EA EA200200666A patent/EA005376B1/ru not_active IP Right Cessation
- 2002-07-12 AR ARP020102609A patent/AR035257A1/es not_active Application Discontinuation
- 2002-07-12 NZ NZ520141A patent/NZ520141A/en unknown
- 2002-07-12 JP JP2002203408A patent/JP3770858B2/ja not_active Expired - Fee Related
- 2002-07-12 AU AU2002300092A patent/AU2002300092B2/en not_active Ceased
- 2002-07-12 HU HU0202284A patent/HUP0202284A3/hu unknown
- 2002-07-12 ZA ZA200205597A patent/ZA200205597B/xx unknown
- 2002-07-12 NO NO20023390A patent/NO20023390L/no not_active Application Discontinuation
- 2002-07-13 KR KR10-2002-0040946A patent/KR100503157B1/ko not_active IP Right Cessation
- 2002-07-15 CN CNB021241627A patent/CN1186318C/zh not_active Expired - Fee Related
- 2002-07-15 CA CA002393995A patent/CA2393995C/fr not_active Expired - Fee Related
-
2003
- 2003-04-17 HK HK03102799A patent/HK1050675A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1339675E (pt) | Compostos bisarilo orto, meta-substituidos, processo para a sua preparacao, sua utilizacao como medicamentos e composicoes farmaceuticas que os contem | |
| PT1150961E (pt) | Derivados do acido pirazolecarboxilico processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT1192122E (pt) | Derivados de benzeno processo para a sua preparacao e composicoes farmaceuticas que os contem | |
| BR9810802B1 (pt) | composto, composição farmacêutica, e, processo para a preparação de um composto. | |
| PT1152765E (pt) | Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem | |
| BR0113494B1 (pt) | processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida. | |
| BR0017030B1 (pt) | derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos | |
| BR9909925B1 (pt) | derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina. | |
| BR9801606B1 (pt) | composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica. | |
| BR9912109B1 (pt) | compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto. | |
| PT1401445E (pt) | Anticolinergico cristalino, processo para a sua preparacao e sua utilizacao para a preparacao de um medicamento | |
| PT1194403E (pt) | Benzenocarbonamidas substituidas com indanilo, processo para a sua preparacao, sua utilizacao como medicamento bem como preparacoes farmaceuticas que as contem | |
| BR0008840B1 (pt) | derivados de camptotecina, processos para a sua preparaÇço, composiÇço farmacÊutica que os compreende e uso dos mesmos. | |
| BR9912104B1 (pt) | compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto. | |
| PT1112266E (pt) | 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem. | |
| PT1122254E (pt) | Derivados de 4-sulfonamidas piperidina, processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT1560826E (pt) | Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem | |
| PT1118610E (pt) | Novos derivados de benzeno-sulfonamida processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT1187847E (pt) | Derivados de estreptograminas sua preparacao e as composicoes que os contem | |
| PT1049706E (pt) | Novos penta-sacaridos os respectivos metodos de producao e as composicoes farmaceuticas que os contem | |
| PT1275647E (pt) | Derivados de octa-hidro-2h-pirido¬1,2-a|pirazina processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT1245565E (pt) | Derivados de indenoindolonas processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| PT1395582E (pt) | Novos derivados de piperidinocarboxamida, metodo para a sua preparacao e composicoes farmaceuticas que os contem | |
| PT1411057E (pt) | Derivados de [3,4-a:3,4-c]carbazole processo para a sua preparacao e as composicoes farmaceuticas que os contem | |
| BR1100524A (pt) | Compostos, processo para sua preparação; compostos intermediários para os mesmos, e composições farmacêuticas |